Director Alcide Barberis filed a Form 4 with the SEC on November 19, 2026, disclosing the acquisition of 120,000 shares of OSR Health, Inc. common stock on October 29, 2026.

Key Highlights

  • Transaction date: October 29, 2026, with 120,000 shares acquired at a price of $0.
  • Transaction code: "A" (acquisition), reported in Table I as non-derivative securities.
  • Grant basis: According to the filing, the shares represent "a fully vested stock award granted under the OSR Health, Inc. 2025 Omnibus Incentive Plan."
  • Lock-up restriction: The filing states the shares "are subject to a six-month contractual lock-up from the grant date."
  • Resulting ownership: Barberis beneficially owns 120,000 shares directly following the transaction, per the filing.
  • Reporting person role: Alcide Barberis is identified as a Director of OSR Health, Inc.

Alcide Barberis Stock Award Details at OSR Health

According to the Form 4 filing, Alcide Barberis, a Director of OSR Health, Inc. (OTC:OSRH), acquired 120,000 shares of the company's common stock on October 29, 2026. The transaction was recorded under Transaction Code "A," indicating an acquisition. The price per share was reported as $0, consistent with an equity award rather than an open-market purchase.

The filing's explanation of responses states that the grant "represents a fully vested stock award granted under the OSR Health, Inc. 2025 Omnibus Incentive Plan." The shares are reported as directly owned by Barberis. However, the filing also notes that the shares "are subject to a six-month contractual lock-up from the grant date," meaning they cannot be transferred or sold during that period following October 29, 2026.

Prior to this transaction, the filing does not indicate any previously held shares; the amount of securities beneficially owned following the reported transaction is listed as 120,000, all held directly. The Form 4 was signed by Timothy Clement Smith as Attorney-in-Fact for Alcide Barberis on November 19, 2026, pursuant to a Power of Attorney listed as Exhibit 24.

What Was Disclosed

The filing disclosed a single acquisition by Director Alcide Barberis of 120,000 fully vested OSR Health shares at $0 under the company's 2025 Omnibus Incentive Plan, with a six-month contractual lock-up applying from the October 29, 2026 grant date.